Filing Details

Accession Number:
0001127602-20-000537
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-03 15:16:30
Reporting Period:
2020-01-02
Accepted Time:
2020-01-03 15:16:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1000697 Waters Corp WAT Laboratory Analytical Instruments (3826) 133668640
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1252013 A Joann Reed 34 Maple Street
Milford MA 01757
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-01-02 4,000 $61.63 25,323 No 4 M Direct
Common Stock Acquisiton 2020-01-02 4,000 $78.10 29,323 No 4 M Direct
Common Stock Acquisiton 2020-01-02 4,000 $75.94 33,323 No 4 M Direct
Common Stock Acquisiton 2020-01-02 4,000 $88.71 37,323 No 4 M Direct
Common Stock Disposition 2020-01-02 5,194 $234.67 32,129 No 4 S Direct
Common Stock Acquisiton 2020-01-02 467 $0.00 32,596 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-01-02 4,000 $0.00 4,000 $61.63
Common Stock Stock Option (Right to Buy) Disposition 2020-01-02 4,000 $0.00 4,000 $78.10
Common Stock Stock Option (Right to Buy) Disposition 2020-01-02 4,000 $0.00 4,000 $75.94
Common Stock Stock Option (Right to Buy) Disposition 2020-01-02 4,000 $0.00 4,000 $88.71
Common Stock Stock Option (Right to Buy) Acquisiton 2020-01-02 1,601 $0.00 1,601 $235.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2011-01-04 2020-01-04 No 4 M Direct
0 2012-01-03 2021-01-03 No 4 M Direct
0 2013-01-03 2022-01-03 No 4 M Direct
0 2014-01-02 2023-01-02 No 4 M Direct
1,601 2021-01-02 2030-01-02 No 4 A Direct
Footnotes
  1. Acquisition of common stock was made under a sale plan established pursuant to the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. Sale of common stock was made under a sale plan established pursuant to the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  3. Grant of shares of common stock subject to restrictions that lapse January 2, 2021.
  4. Options fully vest on January 2, 2021.